Evidence map›Paper›PMID 31356172›Full record

ArticleImmunoHorizons2019

Identification of Novel Respiratory Syncytial Virus CD4

Megan E Schmidt, Steven M Varga

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ImmunoHorizons, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Megan E SchmidtInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA 52242.
Steven M VargaInterdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA 52242; steven-varga@uiowa.edu.ORCID 0000-0001-7332-4290
University of Iowa · US

Funding

PREDOCTORAL TRAINING PROGRAM IN IMMUNOLOGYT32AI007485 · NIAID · UNIVERSITY OF IOWA · PI Kevin L Legge · 1995 to 2026
$5.4M
Balancing protection versus immunopathology by RSV-specific memory CD8 T cellsR01AI124093 · NIAID · UNIVERSITY OF IOWA · PI VARGA, STEVEN M · 2017 to 2020
$1.6M
Flow Cytometry Cell SorterS10OD016199 · OD · UNIVERSITY OF IOWA · PI BALLAS, ZUHAIR K. · 2015 to 2015
$443k
NIAID NIH HHS R01 AI124093NIAID NIH HHS T32 AI007485NIH HHS S10 OD016199ODCDC CDC HHS S10 OD016199
6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection and hospitalization in infants. It is well established that both CD4

Indexed as

AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell Line, TumorEpitopes, T-LymphocyteFemaleHistocompatibility Antigens Class IInterferon-gammaLungMiceMice, Inbred C57BLPeptide LibraryReceptors, Antigen, T-Cell, alpha-betaRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsViral ProteinsEpitopes, T-LymphocyteHistocompatibility Antigens Class IInterferon-gammaPeptide LibraryReceptors, Antigen, T-Cell, alpha-betaViral Proteins

Identifiers

PMID31356172
PMCPMC7316092
OpenAlexW2908786159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.